Efficacy and Safety of JS016 in Patients With SARS-CoV-2 Infection (COVID-19)
Condition(s):COVID-19; SARS-CoV-2Last Updated:October 21, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):COVID-19; SARS-CoV-2Last Updated:October 21, 2021Unknown status
Condition(s):SARS-CoV-2 Infection, Thalasemmie, SCDLast Updated:April 19, 2023Active, not recruiting
Condition(s):COVID-19; Maternal Vaccine Exposure; Respiratory Infections in ChildrenLast Updated:July 7, 2022Recruiting
Condition(s):SARS-CoV2Last Updated:November 22, 2021Completed
Condition(s):COVID-19Last Updated:July 26, 2022Terminated
Condition(s):COVID 19Last Updated:February 25, 2021Unknown status
Condition(s):Chronic Kidney Disease 5D; Chronic Kidney Disease 5TLast Updated:July 20, 2022Completed
Condition(s):COVID-19; SARS-CoV-2 PneumoniaLast Updated:July 20, 2022Unknown status
Condition(s):HealthyLast Updated:July 27, 2023Completed
Condition(s):COVID-19; Therapeutic Vaccine; BCG; SARS-CoV 2; TransmissionLast Updated:November 30, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.